Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
2017 1
2020 1
2021 2
2022 5
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Cilgavimab/Tixagevimab as alternative therapeutic approach for BA.2 infections.
Dichtl S, Zaderer V, Kozubowski V, Abd El Halim H, Lafon E, Lanser L, Weiss G, Lass-Flörl C, Wilflingseder D, Posch W. Dichtl S, et al. Among authors: lafon e. Front Med (Lausanne). 2022 Sep 29;9:1005589. doi: 10.3389/fmed.2022.1005589. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36250084 Free PMC article.
[Supporting people with Diogenes syndrome].
Patry C, Closier S, Lafon É, Carlier-Verhaeghe C, Kerrien A, Bertrand A, Caudron E. Patry C, et al. Among authors: lafon e. Rev Infirm. 2017 Dec;66(236):34-36. doi: 10.1016/j.revinf.2017.10.014. Rev Infirm. 2017. PMID: 29179846 French.
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E, Diem G, Witting C, Zaderer V, Bellmann-Weiler RM, Reindl M, Bauer A, Griesmacher A, Fux V, Hoermann G, Miller C, Zabernigg A, Wöll E, Wilflingseder D, Lass-Flörl C, Posch W. Lafon E, et al. Front Immunol. 2021 Jun 14;12:684014. doi: 10.3389/fimmu.2021.684014. eCollection 2021. Front Immunol. 2021. PMID: 34194438 Free PMC article.
More Efficient Complement Activation by Anti-Aquaporin-4 Compared With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies.
Lerch M, Schanda K, Lafon E, Würzner R, Mariotto S, Dinoto A, Wendel EM, Lechner C, Hegen H, Rostásy K, Berger T, Wilflingseder D, Höftberger R, Reindl M. Lerch M, et al. Among authors: lafon e. Neurol Neuroimmunol Neuroinflamm. 2022 Nov 22;10(1):e200059. doi: 10.1212/NXI.0000000000200059. Print 2023 Jan. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 36414427 Free PMC article.